Widespread Claims Misrepresent Effectiveness of COVID-19 Vaccines
SciCheck Digest
As the virus that causes COVID-19 has evolved, the vaccines have become less effective in preventing symptomatic infection while remaining highly effective in preventing severe disease and death. This shift has been misrepresented by anti-vaccine influencers who falsely claim that it means the vaccines don’t work and have been ineffective all along.
All of the authorized and approved vaccines are effective at preventing severe COVID-19.
Against earlier forms of the coronavirus, the vaccines were highly effective at preventing symptomatic illness. For example, the Pfizer/BioNTech vaccine, which was the first COVID-19 vaccine to receive full approval from the Food and Drug Administration, showed a final efficacy of 91% against symptomatic illness in its phase 3 trial, meaning that under the conditions of the trial the vaccine reduced the risk of getting sick by 91%.
The Moderna vaccine showed similar results in its clinical trial, with a final efficacy of 93%. It has also received FDA approval.
Johnson & Johnson, which partly tested its vaccine in South Africa when the beta variant emerged, reported an efficacy of 66% in preventing moderate to severe COVID-19 and an efficacy of 85% in preventing severe or critical COVID-19 in its clinical trial
You’re reading a preview, subscribe to read more.
Start your free 30 days